ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
61 388,84
0,97%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Alpha Healthcare Acquisition Corporation III (ALPA)

  7. Alpha Healthcare Acquisition Corporation III (ALPA) Actualités

ALPA

Alpha Healthcare Acquisi... (ALPA)

Alpha Healthcare Acquisition Corporation III
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALPA
DateHeureSourceTitreSymboleSociété
14/07/202321h12Business WireAlpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics CorporationNASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
27/06/202314h29Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
27/06/202314h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
27/06/202313h00Business WireAlpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business CombinationNASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
26/06/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
21/06/202312h06Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
16/05/202322h04Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
15/05/202322h04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
23/03/202319h46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
21/03/202320h34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
17/03/202321h04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
05/01/202304h11Business WireAlpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing IndicationsNASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
13/09/202212h01Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
09/09/202222h54Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
31/03/202223h29Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:ALPAAlpha Healthcare Acquisition Corporation III
 Showing the most relevant articles for your search:NASDAQ:ALPA

Dernières Valeurs Consultées

NYSE
MRK
Merck
EU
CS
Axa
EU
EN
Bouygues
EU
RNO
Renault
EU
ACA
Credit Agricole
NYSE
KO
Coca Cola
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
EU
AI
Air Liquide
EU
RI
Pernod Ricard
NASDAQ
AMZN
Amazon.com
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés